These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 9615103

  • 1. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
    Tessier MH, Mansat E, Legoux B, Litoux P, Dreno B.
    Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
    [Abstract] [Full Text] [Related]

  • 2. [Combination of dacarbazine, vindesine and interferon alpha in the treatment of metastatic melanoma].
    Mansat-Krzyzanowska E, Dreno B.
    Ann Dermatol Venereol; 1994; 121(12):884-7. PubMed ID: 7632005
    [Abstract] [Full Text] [Related]

  • 3. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Célérier P, Dreno B, Bureau B, Litoux P.
    Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.
    Lissoni P, Vaghi M, Ardizzoia A, Malugani F, Fumagalli E, Bordin V, Fumagalli L, Bordoni A, Mengo S, Gardani GS, Tancini G.
    In Vivo; 2002; 16(2):93-6. PubMed ID: 12073777
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A, Ascierto PA, Gravina A, Melucci MT, Palmieri G, Comella P, Cellerino R, DeLena M, Marini G, Comella G, Italian Cooperative Oncology Group.
    Cancer; 2000 Dec 15; 89(12):2630-6. PubMed ID: 11135225
    [Abstract] [Full Text] [Related]

  • 7. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
    Fierro MT, Bertero M, Novelli M, Appino A, Doveil GC, Colonna S, Bernengo MG.
    Melanoma Res; 1993 Apr 15; 3(2):127-31. PubMed ID: 8518551
    [Abstract] [Full Text] [Related]

  • 8. Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.
    Legha SS, Ring S, Eton O, Bedikian A, Plager C, Papadopoulos N.
    Cancer J Sci Am; 1997 Dec 15; 3 Suppl 1():S9-15. PubMed ID: 9457387
    [Abstract] [Full Text] [Related]

  • 9. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
    Pyrhönen S, Hahka-Kemppinen M, Muhonen T, Nikkanen V, Eskelin S, Summanen P, Tarkkanen A, Kivelä T.
    Cancer; 2002 Dec 01; 95(11):2366-72. PubMed ID: 12436444
    [Abstract] [Full Text] [Related]

  • 10. Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG).
    Hauschild A, Garbe C, Stolz W, Ellwanger U, Seiter S, Dummer R, Ugurel S, Sebastian G, Nashan D, Linse R, Achtelik W, Mohr P, Kaufmann R, Fey M, Ulrich J, Tilgen W.
    Br J Cancer; 2001 Apr 20; 84(8):1036-42. PubMed ID: 11308250
    [Abstract] [Full Text] [Related]

  • 11. Subcutaneous interleukin-2 and interferon-alpha therapy associated with cisplatin monochemotherapy in the treatment of metastatic melanoma.
    Andrès P, Cupissol D, Guillot B, Avril MF, Drèno B.
    Eur J Dermatol; 1998 Jun 20; 8(4):235-9. PubMed ID: 9649695
    [Abstract] [Full Text] [Related]

  • 12. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy.
    Legha SS.
    Semin Oncol; 1997 Feb 20; 24(1 Suppl 4):S39-43. PubMed ID: 9122733
    [Abstract] [Full Text] [Related]

  • 13. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
    Middleton MR, Lorigan P, Owen J, Ashcroft L, Lee SM, Harper P, Thatcher N.
    Br J Cancer; 2000 Mar 20; 82(6):1158-62. PubMed ID: 10735499
    [Abstract] [Full Text] [Related]

  • 14. DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma.
    Rudolf Z, Strojan P.
    Neoplasma; 1996 Mar 20; 43(2):93-7. PubMed ID: 8843969
    [Abstract] [Full Text] [Related]

  • 15. Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
    Papadopoulos NE, Bedikian A, Ring S, Kim KB, Hwu WJ, Gerber DL, Homsi J, Hwu P.
    Am J Clin Oncol; 2009 Oct 20; 32(5):509-14. PubMed ID: 19506454
    [Abstract] [Full Text] [Related]

  • 16. A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.
    Agarwala SS, Ferri W, Gooding W, Kirkwood JM.
    Cancer; 1999 May 01; 85(9):1979-84. PubMed ID: 10223239
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH, Ang PT.
    Singapore Med J; 1996 Apr 01; 37(2):165-7. PubMed ID: 8942255
    [Abstract] [Full Text] [Related]

  • 18. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
    Hofmann MA, Sterry W, Trefzer U.
    Jpn J Clin Oncol; 2007 Mar 01; 37(3):224-9. PubMed ID: 17472972
    [Abstract] [Full Text] [Related]

  • 19. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
    Thompson JA, Gold PJ, Fefer A.
    Semin Oncol; 1997 Feb 01; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
    [Abstract] [Full Text] [Related]

  • 20. Our experience with interferon alpha: metastatic malignant melanoma.
    Merimsky O, Chaitchik S.
    Mol Biother; 1992 Sep 01; 4(3):135-8. PubMed ID: 1445667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.